{
    "organizations": [],
    "uuid": "4b0562d3f01854ff97ccc73a4d8612c495cff2f7",
    "author": "",
    "url": "https://www.reuters.com/article/brief-novartis-drug-afinitor-disperz-rec/brief-novartis-drug-afinitor-disperz-receives-fda-approval-to-treat-tsc-associated-partial-onset-seizures-idUSASC09VHM",
    "ord_in_thread": 0,
    "title": "BRIEF-Novartis Drug Afinitor Disperz Receives FDA Approval To Treat TSC-Associated Partial Onset Seizures",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 10 (Reuters) - Novartis AG:\n* NOVARTIS DRUG AFINITOR DISPERZÂ® RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL - ONSET SEIZURES\n* AFINITOR DISPERZ RECEIVES FDA APPROVAL TO TREAT TSC-ASSOCIATED PARTIAL-ONSET SEIZURES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-04-11T02:57:00.000+03:00",
    "crawled": "2018-04-11T04:15:17.014+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "novartis",
        "ag",
        "novartis",
        "drug",
        "afinitor",
        "receives",
        "fda",
        "approval",
        "treat",
        "partial",
        "onset",
        "seizure",
        "afinitor",
        "disperz",
        "receives",
        "fda",
        "approval",
        "treat",
        "seizure",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}